The CDC says that in order to avoid catching the Coronavirus, don’t touch your face. Impossible, you say. Here’s the CDC’s recommendation.
From the Washington Post, “How to prepare for coronavirus in the U.S. (Spoiler: Not sick? No need to wear a mask.)” Unless, of course, you want to make a CDC Chic fashion statement.
There are the exam gloves, the surgical masks, the dubious supplements and the deceptive disinfectants. If unchecked Internet information is any guide, there’s an inexhaustible list of products “you should buy” to prepare for the spread of coronavirus — which, according to U.S. health officials, now appears inevitable.
But here’s the thing: Covid-19 may be novel, but you really don’t need to buy anything new or special to brace for it. In fact, The Washington Post spoke to epidemiology experts, and they said the most important aspect of preparedness costs nothing at all: calm.
Okay. But here’s something you really can get excited about – High Fashion CDC Chic
One mutation away from disaster: Coronavirus exposes a huge weakness in our national preparedness
Our inattentiveness as a nation to biodefense has resulted in this alarming truth: We are one mutation away from biological disaster. Just one genetic change and a virus like coronavirus or influenza can become far more contagious and lethal, or the antibiotics we depend on to kill bacteria can be rendered ineffective.
Rule Z – There is never, ever just one zombie.
According to Reuters, “Obama seeks funds to fight Zika; (but) sees no cause for panic“.
President Barack Obama will ask the U.S. Congress for more than $1.8 billion in emergency funds to fight Zika at home and abroad and pursue a vaccine, the White House said on Monday, but Obama also said there was no reason to panic over the mosquito-borne virus.
Zika, spreading rapidly in South and Central America and the Caribbean, has been linked to severe birth defects in Brazil and public health officials’ concern is focused on pregnant women and women who may become pregnant.
Obama’s request to Congress includes $200 million for research, development and commercialization of new vaccines and diagnostic tests for the virus.